Efficacy and safety of mechanochemical ablation versus laser ablation in the treatment of primary great saphenous vein reflux: A randomized,open,parallel controlled clinical trial
Restricted accessResearch articleFirst published online April, 2025
Efficacy and safety of mechanochemical ablation versus laser ablation in the treatment of primary great saphenous vein reflux: A randomized,open,parallel controlled clinical trial
To evaluate the efficacy of a new mechanochemical ablation (MOCA) device versus endovenous laser ablation (EVLA) for primary great saphenous vein (GSV) reflux.
Materials and methods
Prospectively analyze the demographics, treatment detail and outcomes data of 57 primary GSV reflux patients. Patients were randomly assigned to MOCA or EVLA group with random envelope method. Primary endpoint was 6-month closure rate of GSV. Secondary endpoint including technical success rate, the venous clinical severity score (VCSS), chronic venous insufficiency questionnaire (CIVIQ-20) score and visual analogue scale (VAS) for pain.
Results
The procedures were well tolerated according to the VAS score. The 6-month closure rate was 85.71% in MOCA and 96.55% in EVLA group (p = .194). Significant changes were observed in regard of VCSS and CIVIQ-20 score at 6-month follow-up. Skin paresthesia occurred in 0 in MOCA and 5 in EVLA group.
Conclusion
The new MOCA device is safe and effective in treating primary great saphenous vein reflux. The 6-month closure rate is non-inferior compared with EVLA. However, the long-term results need further follow-up.
EvansCJFowkesFGRuckleyCV, et al.Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health1999; 53(3): 149–153. DOI: 10.1136/jech.53.3.149.
3.
KurzXLampingDLKahnSR, et al.Do varicose veins affect quality of life? Results of an international population-based study. J Vasc Surg2001; 34(4): 641–648. DOI: 10.1067/mva.2001.117333.
4.
SmithJJGarrattAMGuestMGRM, et al.Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg1999; 30(4): 710–719. DOI: 10.1016/s0741-5214(99)70110-2.
RabeEPannierF. Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology2012; 27(Suppl 1): 114–118. DOI: 10.1258/phleb.2012.012s19.
7.
PichotODe MaeseneerM. Treatment of varicose veins: does each technique have a formal indication?Perspect Vasc Surg Endovasc Ther2011; 23(4): 250–254. DOI: 10.1177/1531003511433337.
8.
MarsdenGPerryMKelleyK, et al.Guideline Development Group. Diagnosis and management of varicose veins in the legs: summary of NICE guidance. BMJ2013; 347: f4279. DOI: 10.1136/bmj.f4279.
9.
BootunRLaneTRDaviesAH. The advent of non-thermal, non-tumescent techniques for treatment of varicose veins. Phlebology2016; 31(1): 5–14. DOI: 10.1177/0268355515593186.
10.
WhingJNandhraSNesbittC, et al.Interventions for great saphenous vein incompetence. Cochrane Database Syst Rev2021; 8(8): CD005624. DOI: 10.1002/14651858.CD005624.pub4.
11.
AhadiatOHigginsSLyA, et al.Review of endovenous thermal ablation of the great saphenous vein: endovenous laser therapy versus radiofrequency ablation. Dermatol Surg2018; 44(5): 679–688. DOI: 10.1097/DSS.0000000000001478.
12.
KerverALvan der HamACTheeuwesHP, et al.The surgical anatomy of the small saphenous vein and adjacent nerves in relation to endovenous thermal ablation. J Vasc Surg2012; 56(1): 181–188. DOI: 10.1016/j.jvs.2011.11.127.
13.
Rodriguez-AcevedoOElstnerKEMartinicK, et al.Hydrodisplacement of sural nerve for safety and efficacy of endovenous thermal ablation for small saphenous vein incompetence. Phlebology2017; 32(7): 482–487. DOI: 10.1177/0268355516671233.
14.
BoersmaDKornmannVNvan EekerenRR, et al.Treatment modalities for small saphenous vein insufficiency: systematic review and meta-analysis. J Endovasc Ther2016; 23(1): 199–211. DOI: 10.1177/1526602815616375.
15.
YangBNieQQFanXQ, et al.Histopathological analysis of incompetent great saphenous veins after mechanochemical ablation treatment - an ex-vivo experiment. Vascular2022; 30(2): 349–356. DOI: 10.1177/17085381211007613.
16.
VähäahoSHalmesmäkiKMahmoudO, et al.Three-year results of a randomized controlled trial comparing mechanochemical and thermal ablation in the treatment of insufficient great saphenous veins. J Vasc Surg Venous Lymphat Disord2021; 9(3): 652–659. DOI: 10.1016/j.jvsv.2020.08.007.
17.
KimPSBishawiMDraughnD, et al.Mechanochemical ablation for symptomatic great saphenous vein reflux: a two-year follow-up. Phlebology2017; 32(1): 43–48. DOI: 10.1177/0268355515627260.
18.
WitteMEHolewijnSvan EekerenRR, et al.Midterm outcome of mechanochemical endovenous ablation for the treatment of great saphenous vein insufficiency. J Endovasc Ther2017; 24(1): 149–155. DOI: 10.1177/1526602816674455.
19.
VähäahoSMahmoudOHalmesmäkiK, et al.Randomized clinical trial of mechanochemical and endovenous thermal ablation of great saphenous varicose veins. Br J Surg2019; 106(5): 548–554. DOI: 10.1002/bjs.11158.
20.
BontinisVBontinisAKoutsoumpelisA, et al.A network meta-analysis on the efficacy and safety of thermal and nonthermal endovenous ablation treatments. J Vasc Surg Venous Lymphat Disord2023; 11(4): 854–865. DOI: 10.1016/j.jvsv.2023.03.011.
21.
McAreeBIkponmwosaABrockbankK, et al.Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model. Eur J Vasc Endovasc Surg2012; 43(6): 721–725. DOI: 10.1016/j.ejvs.2012.02.026.
22.
HolewijnSvan EekerenRRJPVahlA, et al.MARADONA study group. Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial). J Vasc Surg Venous Lymphat Disord2019; 7(3): 364–374. DOI: 10.1016/j.jvsv.2018.12.014.
23.
BoersmaDvan HaelstSTvan EekerenRR, et al.Macroscopic and histologic analysis of vessel wall reaction after mechanochemical endovenous ablation using the ClariVein OC device in an animal model. Eur J Vasc Endovasc Surg2017; 53(2): 290–298. DOI: 10.1016/j.ejvs.2016.11.024.
24.
van EekerenRRBoersmaDKonijnV, et al.Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg2013; 57(2): 445–450. DOI: 10.1016/j.jvs.2012.07.049.
